412 results
Intracoronary imaging: PCI guidance
14 May 2024 – From EuroPCR 2024
This session explores the use of various intracoronary imaging techniques to guide complex PCI procedures. It covers cases demonstrating the application of IVUS, OCT, and other imaging modalities in simplifying bifurcation PCI, managing restenotic DES ISR, assessing post-transplant vasculopathy, and optimizing PCI planning and precision. The...
Primary PCI in different situations
14 May 2024 – From EuroPCR 2024
This session, in collaboration with various international cardiology societies, focuses on the management of primary PCI in different challenging situations. It presents three cases: a late-comer STEMI patient requiring unconventional techniques, a STEMI patient with a free-floating thrombus in the left main, and a STEMI patient...
What about MINOCA?
14 May 2024 – From EuroPCR 2024
This session focuses on the topic of Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA). It covers the mechanisms underlying MINOCA, the criteria for its diagnosis, and the management of patients with this condition. The session provides insights from both the clinician's and the patient's perspectives, addressing...
The future of STEMI care: a new treatment for bridging the gap from diagnosis to treatment
14 May 2024 – From EuroPCR 2024
Watch this session to delve into the crucial role of pre-hospital STEMI diagnosis and treatment. Gain insights into the significance of early intervention and explore previous facilitated PCI trials in STEMI. Additionally, learn about a promising new agent for pre-hospital STEMI treatment, offering potential advancements in...
How the latest recommendations on MINOCA can impact our practice
14 May 2024 – From EuroPCR 2024
Join Vijay Kunadian and Salvatore Brugaletta as they talk about the latest ESC guidelines for MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries). Together, they review the crucial aspects of identifying MINOCA patients, how to diagnose them effectively using available diagnostic tools and the importance of post-treatment...
Mechanical circulatory support in cardiogenic shock: where are we now?
14 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 interview, Alaide Chieffo and Gabor Toth discuss mechanical circulatory support in cardiogenic shock and myocardial infarction. They address the ECLS-SHOCK trial's lack of benefit from prophylactic ECMO, stressing improved patient selection and timing. They contrast this with the DanGer Shock study, where...
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
Percutaneous transvalvular micro-axial flow pump in infarct related cardiogenic shock: Results of the DANGER-shock Trial
07 Apr 2024
Mirvat Alasnag interviews Jacob Eifer Møller about the results of the DANGER-shock Trial which he presented at the ACC.24 in Atlanta.
Results show that the implantation of microaxial flow pump post-heart attack significantly boosts survival in patients with STEMI-related cardiogenic shock, though with increased complications. The trial's positive...
Author
Author
One-month ticagrelor monotherapy after PCI in acute coronary syndromes: Principal results from the double-blind, placebo-controlled Ultimate DAPT trial
07 Apr 2024
Elad Asher provides his take on the ULTIMATE-DAPT Trial results which Gregg W Stone presented at ACC.24 in Atlanta.
Author
PCRonline @ ACC.24 Scientific Sessions
22 Mar 2024
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2024 Scientific Sessions #ACC24
